REG - Rights and Issues IT - Share Repurchase Programme

Rights and Issues Investment TrustAnnouncement

Today 11:30

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260327:nRSa4767Ya&default-theme=true

RNS Number : 4767Y  Rights and Issues Inv. Trust PLC  27 March 2026

Rights and Issues Investment Trust plc ('the Company')

LEI:       2138002AWAM93Z6BP574

12 month Share Repurchase Programme in accordance with Discount Management
Policy

Following the passing of the Special resolution authorising the Company to buy
back shares at the Annual General Meeting held on 26 March 2026, Rights and
Issues Investment Trust plc announces that the share repurchase programme
which lapsed at the conclusion of the Annual General Meeting in 2025 has been
reinstated with immediate effect for a period of 12 months to 26 March 2027.
Cavendish Capital Markets Limited ("Cavendish") has been authorised to
repurchase ordinary shares of 25p each ("Shares") on its behalf and within
certain pre-set parameters between 27 March 2026 and 26 March 2027 (the
"Buyback Period").

The Directors of the Company confirm that they are satisfied that all inside
information known to the Directors and the Company up to the date of this
notice has been notified to a Regulated Information Service ("RIS").
Accordingly, the Company is not prohibited from granting this authority to
Cavendish under the Corporate Broking Agreement.

Purchases of Shares during the Buy-Back Period shall be subject to the
following overriding restrictions:

(i)            the maximum number of Shares acquired shall not, in
aggregate, exceed the authorities granted at the Company's annual general
meeting in 2026.

(ii)           the maximum value of Shares acquired during the
Buy-Back Period shall not exceed, in aggregate, £12.0 million. The maximum
value of Shares acquired during each calendar month of the Buyback Period
shall not, in aggregate, exceed £1.0 million (and pro rata for part months).
However, to the extent that the value of Shares acquired in any month (or part
month) is lower than the maximum value for that month, such excess capacity
shall be carried forward to the following month and increase the maximum value
for the following month accordingly, and so on for subsequent months. For the
avoidance of doubt, there shall be no limit to the number of times an excess
can be carried forward, or the total amount of such excess;

(iii)          the maximum price paid per Share shall be no more than
the highest of: (i) 105% of the average middle market closing prices of the
Shares for the 5 dealing days preceding the date of such purchase; (ii) the
last independent trade price; and (iii) the highest current independent bid
for the Shares when the purchase is carried out;

(iv)         the price paid per Share shall not be more than 95 per
cent. of Cavendish's estimate of the net asset value per Share of the Company
at the time of each purchase; and

(v)          no purchases are to be made on any dealing day when the
Company appears on the Disclosure Table published by the Panel on Takeovers
and Mergers.

The Company shall not (i) exercise any influence over how, when or whether
Cavendish effects share repurchases or (ii) change the number of Shares, price
or timing of the purchases.

 

Enquiries:

 Cavendish Capital Markets Limited
 Andrew Worne / Tunga Chigovanyika - Corporate Finance                      +44 (0) 207 908 6000
 Pauline Tribe - Sales                                                      +44 (0) 207 908 6000
 Apex Fund Administration Services (UK) Limited
 cosec-uk@apexgroup.com                                                     +44 (0) 1245 398950

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  MSCBBGDXCBDDGLR



            Copyright 2019 Regulatory News Service, all rights reserved